In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
After finishing at $1.08 in the prior trading day, AN2 Therapeutics Inc (NASDAQ: ANTX) closed at $1.1, up 1.85%. In other words, the price has increased by $1.85 from its previous closing price. On the day, 0.57 million shares were traded.
Ratios:
Our goal is to gain a better understanding of ANTX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.68 and its Current Ratio is at 8.68. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Leerink Partners on August 09, 2024, Downgraded its rating to Market Perform and sets its target price to $1 from $5 previously.
Leerink Partners Upgraded its Market Perform to Outperform on July 03, 2024, while the target price for the stock was maintained at $5.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 28 ’25 when Leonard Braden Michael sold 200,000 shares for $1.09 per share. The transaction valued at 218,000 led to the insider holds 3,017,432 shares of the business.
Easom Eric bought 10,000 shares of ANTX for $10,665 on Jun 02 ’25. The Chief Executive Officer now owns 256,380 shares after completing the transaction at $1.07 per share. On May 28 ’25, another insider, Leonard Braden Michael, who serves as the 10% Owner of the company, sold 2,100,000 shares for $1.16 each. As a result, the insider received 2,436,000 and left with 3,649,432 shares of the company.
Stock Price History:
Over the past 52 weeks, ANTX has reached a high of $3.07, while it has fallen to a 52-week low of $0.87. The 50-Day Moving Average of the stock is -6.68%, while the 200-Day Moving Average is calculated to be -8.96%.
Shares Statistics:
A total of 30.14M shares are outstanding, with a floating share count of 19.88M. Insiders hold about 34.12% of the company’s shares, while institutions hold 27.44% stake in the company.
